{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:50:11Z","timestamp":1762869011445},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00105-022-05099-x","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:03:01Z","timestamp":1674468181000},"page":"129-136","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sexuell \u00fcbertragbare Infektionen unter dem Einfluss der COVID-19-Pandemie","Sexually transmitted infections under the influence of the COVID-19 pandemic"],"prefix":"10.1007","volume":"74","author":[{"given":"Nico","family":"Nowack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriane","family":"Skaletz-Rorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"5099_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/QAI.0000000000002640","volume":"87","author":"S Pampati","year":"2021","unstructured":"Pampati\u00a0S, Emrick\u00a0K, Siegler\u00a0AJ, Jones\u00a0J (2021) Changes in sexual behavior, PrEP adherence, and access to sexual health services because of the COVID-19 pandemic among a\u00a0cohort of PrEP-using MSM in the south. J\u00a0Acquir Immune Defic Syndr 87:639\u2013643","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5099_CR2","doi-asserted-by":"publisher","first-page":"104239","DOI":"10.1016\/j.amsu.2022.104239","volume":"80","author":"A Nazir","year":"2022","unstructured":"Nazir\u00a0A et al (2022) Rise of syphilis surge amidst COVID-19 pandemic in the USA: a neglected concern. Ann Med Surg 80:104239","journal-title":"Ann Med Surg"},{"key":"5099_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11630-x","volume":"21","author":"A Sent\u00eds","year":"2021","unstructured":"Sent\u00eds\u00a0A et al (2021) The impact of the COVID-19 pandemic on sexually transmitted infections surveillance data: incidence drop or artefact? BMC Public Health 21:1\u20137","journal-title":"BMC Public Health"},{"key":"5099_CR4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s00103-021-03441-7","volume":"64","author":"NH Brockmeyer","year":"2021","unstructured":"Brockmeyer\u00a0NH et al (2021) Sexualverhalten und Pr\u00e4vention sexuell \u00fcbertragbarer Infektionen unter Ber\u00fccksichtigung der SARS-CoV-2-Pandemie. Daten aus einem Versorgungszentrum f\u00fcr sexuelle Gesundheit und Medizin \u2013 WIR Einleitung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 64:1440\u20131451","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"5099_CR5","first-page":"421","volume":"15","author":"S Esser","year":"2017","unstructured":"Esser\u00a0S, Krotzek\u00a0J, Dirks\u00a0H, Scherbaum\u00a0N, Schadendorf\u00a0D (2017) Sexual risk behavior, sexually transmitted infections, and HIV transmission risks in HIV-positive men who have sex with men (MSM)\u2014approaches for medical prevention. J Dtsch Dermatol Ges 15:421\u2013428","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"5099_CR6","first-page":"1","volume-title":"Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2020","author":"M Askar","year":"2021","unstructured":"Askar\u00a0M et\u00a0al (2021) Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2020. Robert Koch Institut, S\u00a01\u2013212"},{"key":"5099_CR7","volume-title":"S2k-Leitlinie Diagnostik und Therapie der Syphilis","author":"AWMF","year":"2021","unstructured":"AWMF (2021) S2k-Leitlinie Diagnostik und Therapie der Syphilis (AWMF-Register Nr.\u00a0059\/002)"},{"key":"5099_CR8","first-page":"1","volume":"47","author":"DN Willrich","year":"2021","unstructured":"Willrich\u00a0DN et al (2021) HIV in Deutschland 2020 | Erfassung der SARS-CoV-2-PCR-Testzahlen. Epidemiol Bull 47:1\u201328","journal-title":"Epidemiol Bull"},{"key":"5099_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/infdis\/jiab319","volume":"224","author":"SL Braunstein","year":"2021","unstructured":"Braunstein\u00a0SL et al (2021) Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City. J\u00a0Infect Dis 224:798\u2013803","journal-title":"J Infect Dis"},{"key":"5099_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/25787489.2021.1975608","volume":"22","author":"LB Brown","year":"2021","unstructured":"Brown\u00a0LB, Spinelli\u00a0MA, Gandhi\u00a0M (2021) The Interplay between HIV and COVID-19: summary of the data and responses to date. HIV Res Clin Pract 22:102\u2013118","journal-title":"HIV Res Clin Pract"},{"key":"5099_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/25787489.2021.1975608","volume":"22","author":"LK Barbera","year":"2021","unstructured":"Barbera\u00a0LK et al (2021) HIV and COVID-19: review of clinical course and outcomes. HIV Res Clin Pract 22:102\u2013118","journal-title":"HIV Res Clin Pract"},{"issue":"8","key":"5099_CR12","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(20)30164-8","volume":"7","author":"P Vizcarra","year":"2020","unstructured":"Vizcarra\u00a0P, Perez-Elias\u00a0MJ, Quereda\u00a0C, Moreno\u00a0A, Vivancos\u00a0MJ, Dronda\u00a0F et al (2020) Description of Covid-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV 7(8):e554\u2013e64","journal-title":"Lancet HIV"},{"issue":"5","key":"5099_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s15010-020-01438-z","volume":"48","author":"G Harter","year":"2020","unstructured":"Harter\u00a0G, Spinner\u00a0CD, Roider\u00a0J, Bickel\u00a0M, Krznaric\u00a0I, Grunwald\u00a0S et al (2020) Covid-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 48(5):681\u2013686","journal-title":"Infection"},{"key":"5099_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2022.04.08.22273605","volume-title":"Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV","author":"C Bessen","year":"2022","unstructured":"Bessen\u00a0C, Plaza-Sirvent\u00a0C, Bhat\u00a0J et al (2022) Impact of SARS-CoV\u20112 vaccination on systemic immune responses in people living with HIV https:\/\/doi.org\/10.1101\/2022.04.08.22273605 (Medrxiv.org)"},{"key":"5099_CR15","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1038\/s41467-022-32263-7","volume":"13","author":"A Vergori","year":"2022","unstructured":"Vergori\u00a0A, Cozzi Lepri\u00a0A, Cicalini\u00a0S et al (2022) Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV. Nat Commun 13:4922. https:\/\/doi.org\/10.1038\/s41467-022-32263-7","journal-title":"Nat Commun"},{"key":"5099_CR16","volume-title":"Deutsch-\u00d6sterreichische Leitlinien zur HIV-Pr\u00e4expositionsprophylaxe","author":"AWMF","year":"2018","unstructured":"AWMF (2018) Deutsch-\u00d6sterreichische Leitlinien zur HIV-Pr\u00e4expositionsprophylaxe (AWMF-Register-Nr.: 055-008)"},{"issue":"5","key":"5099_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/ph14050454","volume":"14","author":"I Zanella","year":"2021","unstructured":"Zanella\u00a0I, Zizioli\u00a0D, Castelli\u00a0F, Quiros-Roldan\u00a0E (2021) Tenofovir, another inexpensive, well-known and widely available old drug repurposed for SARS-COV\u20112 infection. Pharmaceuticals (Basel) 14(5):454","journal-title":"Pharmaceuticals (Basel)"},{"key":"5099_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/QAI.0000000000002581","volume":"86","author":"WPH van Bilsen","year":"2021","unstructured":"van Bilsen\u00a0WPH et al (2021) Sexual behavior and its determinants during covid-19 restrictions among men who have sex with men in Amsterdam. J\u00a0Acquir Immune Defic Syndr 86:288\u2013296","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5099_CR19","doi-asserted-by":"publisher","first-page":"930208","DOI":"10.3389\/fpubh.2022.930208","volume":"10","author":"M Uhrmacher","year":"2022","unstructured":"Uhrmacher\u00a0M, Skaletz-Rorowski\u00a0A, Nambiar\u00a0S, Schmidt\u00a0AJ, Ahaus\u00a0P, Serova\u00a0K, Mordhorst\u00a0I, Kayser\u00a0A, Wach\u00a0J, Tiemann\u00a0C, M\u00fcnstermann\u00a0D, Brockmeyer\u00a0NH, Potthoff\u00a0A (2022) HIV pre-exposure prophylaxis during the SARS-CoV\u20112 pandemic: results from a prospective observational study in Germany. Front Public Health 10:930208. https:\/\/doi.org\/10.3389\/fpubh.2022.930208","journal-title":"Front Public Health"},{"key":"5099_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/sextrans-2020-054881","volume":"97","author":"I Kuitunen","year":"2021","unstructured":"Kuitunen\u00a0I, Ponkilainen\u00a0V (2021) COVID-19-related nationwide lockdown did not reduce the reported diagnoses of chlamydia trachomatis and neisseria gonorrhoeae in Finland. Sex Transm Infect 97:550","journal-title":"Sex Transm Infect"},{"key":"5099_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.amepre.2021.03.009","volume":"61","author":"CN Pinto","year":"2021","unstructured":"Pinto\u00a0CN et al (2021) Impact of the COVID-19 pandemic on chlamydia and gonorrhea screening in the U.S. Am J Prev Med 61:386\u2013393","journal-title":"Am J Prev Med"},{"key":"5099_CR22","volume-title":"S2k-Leitlinie Diagnostik und Therapie der Gonorrhoe","author":"AWMF","year":"2018","unstructured":"AWMF (2018) S2k-Leitlinie Diagnostik und Therapie der Gonorrhoe (AWMF-Register Nr.\u00a0059\/004)"},{"key":"5099_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2340\/actadv.v102.2324","volume":"102","author":"PL Hedley","year":"2022","unstructured":"Hedley\u00a0PL et al (2022) A nationwide observational study of chlamydia trachomatis infections in Denmark during the COVID-19 pandemic. Acta Derm Venereol 102:1\u20135","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"5099_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/sextrans-2020-054608","volume":"97","author":"M Cusini","year":"2021","unstructured":"Cusini\u00a0M, Benardon\u00a0S, Vidoni\u00a0G, Brignolo\u00a0L, Veraldi\u00a0S, Mandolini\u00a0PL (2021) Trend of main STIs during COVID-19 pandemic in Milan, Italy. Sex Transm Infect 97(2):99","journal-title":"Sex Transm Infect"},{"key":"5099_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/jdv.17972","volume":"36","author":"JS Jensen","year":"2022","unstructured":"Jensen\u00a0JS et\u00a0al (2022) 2021 European guideline on the management of mycoplasma genitalium infections. J\u00a0Eur Acad Dermatol Venereol 36:641\u2013650","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5099_CR26","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8913","author":"D Cadosch","year":"2020","unstructured":"Cadosch\u00a0D, Garcia\u00a0V, Jensen\u00a0JS, Low\u00a0N, Althaus\u00a0CL (2020) Understanding the spread of de novo and transmitted macrolide-resistance in mycoplasma genitalium. PeerJ. https:\/\/doi.org\/10.7717\/peerj.8913","journal-title":"PeerJ"},{"key":"5099_CR27","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2022.0287","author":"C Hoffmann","year":"2022","unstructured":"Hoffmann\u00a0C, Jessen\u00a0H, Boesecke\u00a0C (2022) Monkeypox in Germany-initial clinical observations. Dtsch Arztebl Int. https:\/\/doi.org\/10.3238\/arztebl.m2022.0287","journal-title":"Dtsch Arztebl Int"},{"key":"5099_CR28","unstructured":"Robert Koch Institut Internationaler Affenpocken-Ausbruch: Fallzahlen und Einsch\u00e4tzung der Situation in Deutschland Stand: 22.11.2022. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/A\/Affenpocken\/Ausbruch-2022-Situation-Deutschland.html. Zugegriffen: 25. Nov. 2022"},{"key":"5099_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/infdis\/jiab051","volume":"223","author":"SM Jenness","year":"2021","unstructured":"Jenness\u00a0SM et al (2021) Projected HIV and bacterial sexually transmitted infection incidence following COVID-19-related sexual distancing and clinical service interruption. J\u00a0Infect Dis 223:1019\u20131028","journal-title":"J Infect Dis"},{"issue":"3","key":"5099_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/all.14498","volume":"76","author":"N Novak","year":"2021","unstructured":"Novak\u00a0N, Peng\u00a0W, Negeli\u00a0M et al (2021) SARS-CoV\u20112, COVID-19, skin and immunology\u2014what do we know so far? Allergy 76(3):698\u2013713","journal-title":"Allergy"},{"key":"5099_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2021.11.003","author":"YC Manabe","year":"2021","unstructured":"Manabe\u00a0YC (2021) The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections. Clin Biochem. https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.11.003","journal-title":"Clin Biochem"},{"key":"5099_CR32","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/OLQ.0000000000001313","volume":"48","author":"C Carnevale","year":"2021","unstructured":"Carnevale\u00a0C et al (2021) At home testing for sexually transmitted infections during the COVID-19 pandemic. Sex Transm Dis 48:e11\u2013e14","journal-title":"Sex Transm Dis"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-05099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-022-05099-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-05099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T19:47:53Z","timestamp":1728762473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-022-05099-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["5099"],"URL":"https:\/\/doi.org\/10.1007\/s00105-022-05099-x","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"6 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>N.\u00a0Nowack<\/b>: A.\u00a0Finanzielle Interessen: Reisekostenerstattung i.\u202fR. des Campus Infektiologie 2022, Gilead Sciences.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt Dermatologie, Klinik f\u00fcr Dermatologie und Venerologie, Katholische Kliniken Bochum gGmbH, Bochum. <b>A.\u00a0Skaletz-Rorowski<\/b>: A.\u00a0Finanzielle Interessen: Honorar und Reisekostenerstattung i.\u202fR. der DAGN\u00c4 und des Kongresses der Deutschen Gesellschaft f\u00fcr Suchtmedizin, AbbVie.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrende Leiterin des WIR-Walk In Ruhr, Zentrum f\u00fcr Sexuelle Gesundheit und Medizin, Klinik f\u00fcr Dermatologie, Venerologie und Allergologie der Ruhr-Universit\u00e4t Bochum, Katholisches Klinikum Bochum gGmbH, Bochum. <b>A.\u00a0Potthoff<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Personalmittel: ViiV Health Care, AbbVie, PKV.\u00a0\u2013 Advisory Board ViiV, MSD, Reise\/Kongresskosten Gilead.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin, seit 01.07.2021 Leitende Abteilungs\u00e4rztin, WIR\u00a0\u2013 Walk In Ruhr; Zentrum f\u00fcr Sexuelle Gesundheit und Medizin, Klinik f\u00fcr Dermatologie, Venerologie und Allergologie der Ruhr-Universit\u00e4t Bochum | Mitgliedschaften\/Funktionen in Interessenverb\u00e4nden: DAIG, DGI, DDG, DSTIG (Schatzmeisterin).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}